As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Insights from multimodal datasets on the platform fuel cancer research in Canada
BOSTON and ROLLE, Switzerland, Jan. 8, 2024 /PRNewswire/ SOPHiA GENETICS , a cloud-native software company and a.
SOPHiA GENETICS , a cloud-native software company and a leader in data-driven medicine, today announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through.
Share this article
Share this article
Jersey City, N.J., June 9, 2021 /PRNewswire/ Verified Market Research recently published a report, Proteomics Market By Reagent (Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents & Others), By Instrumentation Technology (X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation & Others), By Software and Service (Core Proteomics Services and Bioinformatics Software and Services), By Application (Clinical Diagnostics, Drug Discovery and Other Applications), and By Geography. According to Verified Market Research, the Global Proteomics Market was valued at USD 21.64 Billion in 2020 and is projected to reach USD 73.17 Billion by 2028, growing at a CAGR of 16.50% from 2021 to 2028.
- The growth of the market can be attributed to a growth in research activities surrounding personalized medicine, increasing investments in R&D by Pharmaceutical and Biotechnology Companies